Imperial College London

MIT researchers used generative AI to design two novel antibiotics capable of killing drug-resistant gonorrhea and MRSA in laboratory and animal tests.

Imperial College London's REACT programme, which built a 2.5 million participant cohort during COVID-19, will partner with the Dementia Trials Accelerator to address chronic recruitment challenges in UK dementia clinical trials.

The TOPSPIN trial, led by AIIMS Delhi, found that three commonly used two-drug combination pills for hypertension showed equal effectiveness in reducing blood pressure among South Asian patients, with all combinations achieving approximately 14/8 mmHg reduction in 24-hour ambulatory measurements.

Modus Therapeutics announced a fully secured rights issue of SEK 28.3 million to finance continued clinical development of sevuparin, a drug candidate for chronic kidney disease with anemia.

MAIA Biotechnology appointed two prominent hepatocellular carcinoma specialists, Dr. Claudia Fulgenzi and Dr. David J. Pinato, to its Scientific Advisory Board to guide upcoming clinical trials.

A randomized controlled trial involving 292 children across four African countries found that intravenous rehydration was as safe as oral rehydration for children with severe acute malnutrition and gastroenteritis.

P2Y12 inhibitors including ticagrelor and clopidogrel demonstrated a 23% lower risk of cardiovascular death, heart attack, or stroke compared to aspirin in patients following coronary stent placement.

Metsera will present clinical data from its completed Phase 1/2 trial of MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, at the 85th Scientific Sessions of the American Diabetes Association.

Global rheumatoid arthritis incidence increased 13.2% from 1990 to 2021, affecting 17.9 million people worldwide by 2021, with significant regional disparities and a shift toward younger age groups.

England becomes the first country globally to implement a gonorrhoea vaccination program, targeting high-risk populations as infections reach record levels with over 85,000 cases reported in 2023.